A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro

por Xing, Yu-jie, Liu, Biao-hu, Wan, Shu-jun, Cheng, Yi, Zhou, Si-min, Sun, Yue, Yao, Xin-ming, Hua, Qiang, Meng, Xiang-jian, Cheng, Jin-han, Zhong, Min, Zhang, Yan, Lv, Kun, Kong, Xiang
Publicado 2021